Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis

被引:1059
作者
Wang, Zeneng [1 ]
Roberts, Adam B. [1 ]
Buffa, Jennifer A. [1 ]
Levison, Bruce S. [1 ]
Zhu, Weifei [1 ]
Org, Elin [2 ]
Gu, Xiaodong [1 ]
Huang, Ying [1 ]
Zamanian-Daryoush, Maryam [1 ]
Culley, Miranda K. [1 ]
DiDonato, Anthony J. [1 ]
Fu, Xiaoming [1 ]
Hazen, Jennie E. [1 ]
Krajcik, Daniel [1 ]
DiDonato, Joseph A. [1 ]
Lusis, Aldons J. [2 ]
Hazen, Stanley L. [1 ,3 ]
机构
[1] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44195 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA
[3] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA
关键词
CONTAINING MONOOXYGENASE 3; N-OXIDE; INTESTINAL MICROBIOTA; PROGNOSTIC VALUE; CHOLINE; METABOLISM; PHOSPHATIDYLCHOLINE; DEGRADATION; DISEASE; BETAINE;
D O I
10.1016/j.cell.2015.11.055
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Trimethylamine (TMA) N-oxide (TMAO), a gut-microbiota-dependent metabolite, both enhances atherosclerosis in animal models and is associated with cardiovascular risks in clinical studies. Here, we investigate the impact of targeted inhibition of the first step in TMAO generation, commensal microbial TMA production, on diet-induced atherosclerosis. A structural analog of choline, 3,3-dimethyl-1-butanol (DMB), is shown to non-lethally inhibit TMA formation from cultured microbes, to inhibit distinct microbial TMA lyases, and to both inhibit TMA production from physiologic polymicrobial cultures (e.g., intestinal contents, human feces) and reduce TMAO levels in mice fed a high-choline or L-carnitine diet. DMB inhibited choline diet-enhanced endogenous macrophage foam cell formation and atherosclerotic lesion development in apolipoprotein e(-/-) mice without alterations in circulating cholesterol levels. The present studies suggest that targeting gut microbial production of TMA specifically and non-lethal microbial inhibitors in general may serve as a potential therapeutic approach for the treatment of cardiometabolic diseases.
引用
收藏
页码:1585 / 1595
页数:11
相关论文
共 34 条
[1]  
Baglione Julie, 2006, V129, P83
[2]   Trimethylamine: Metabolic, pharmacokinetic and safety aspects [J].
Bain, MA ;
Fornasini, G ;
Evans, AM .
CURRENT DRUG METABOLISM, 2005, 6 (03) :227-240
[3]   THE EFFECTS OF INHIBITING CHOLINE DEHYDROGENASE ON CHOLINE METABOLISM IN MICE [J].
BARLOW, P ;
MARCHBANKS, RM .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (17) :3117-3122
[4]   Trimethylamine-N-Oxide, a Metabolite Associated with Atherosclerosis, Exhibits Complex Genetic and Dietary Regulation [J].
Bennett, Brian J. ;
Vallim, Thomas Q. de Aguiar ;
Wang, Zeneng ;
Shih, Diana M. ;
Meng, Yonghong ;
Gregory, Jill ;
Allayee, Hooman ;
Lee, Richard ;
Graham, Mark ;
Crooke, Rosanne ;
Edwards, Peter A. ;
Hazen, Stanley L. ;
Lusis, Aldons J. .
CELL METABOLISM, 2013, 17 (01) :49-60
[5]   The Gut Microbial Endocrine Organ: Bacterially Derived Signals Driving Cardiometabolic Diseases [J].
Brown, J. Mark ;
Hazen, Stanley L. .
ANNUAL REVIEW OF MEDICINE, VOL 66, 2015, 66 :343-359
[6]  
CAFIERO M, 1951, Boll Soc Ital Biol Sper, V27, P1426
[7]   Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria [J].
Cashman, JR ;
Camp, K ;
Fakharzadeh, SS ;
Fennessey, PV ;
Hines, RN ;
Mamer, OA ;
Mitchell, SC ;
Preti, G ;
Schlenk, D ;
Smith, RL ;
Tjoa, SS ;
Williams, DE ;
Yannicelli, S .
CURRENT DRUG METABOLISM, 2003, 4 (02) :151-170
[8]   APPLICATIONS OF NEXT-GENERATION SEQUENCING The human microbiome: at the interface of health and disease [J].
Cho, Ilseung ;
Blaser, Martin J. .
NATURE REVIEWS GENETICS, 2012, 13 (04) :260-270
[9]   Altering the Intestinal Microbiota during a Critical Developmental Window Has Lasting Metabolic Consequences [J].
Cox, Laura M. ;
Yamanishi, Shingo ;
Sohn, Jiho ;
Alekseyenko, Alexander V. ;
Leung, Jacqueline M. ;
Cho, Ilseung ;
Kim, Sungheon G. ;
Li, Huilin ;
Gao, Zhan ;
Mahana, Douglas ;
Rodriguez, Jorge G. Zarate ;
Rogers, Arlin B. ;
Robine, Nicolas ;
Loke, P'ng ;
Blaser, Martin J. .
CELL, 2014, 158 (04) :705-721
[10]   Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme [J].
Craciun, Smaranda ;
Balskus, Emily P. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (52) :21307-21312